Autoimmune Diseases  >>  CS-0777  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
CS-0777 / Daiichi Sankyo
NCT00616733: 12-week Safety Evaluation of Oral CS-0777 in Multiple Sclerosis Patients

Checkmark Data
Apr 2012 - Apr 2012: Data
Completed
1
25
US
CS-0777 tablets
Daiichi Sankyo, Inc.
Multiple Sclerosis
09/10
09/10

Download Options